Benzoic acid;2-phenylacetic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzoic acid;2-phenylacetic acid
• 化学式: C15H14O4
• 分子量: 258.27
• InChiKey: NZVQEDALJLUOLW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Hydroformylation process
  申请人：EXXON RESEARCH AND ENGINEERING COMPANY

  公开号：EP0071281A2

  公开（公告）日：1983-02-09

  This invention concerns a continuous hydroformylation process comprising reacting an olefinic compound with hydrogen and carbon monixide in the presence of a reaction mixture comprising (1) a rhodium-containing catalyst having no reactive halogen and having at least one ligand complexed with said rhodium, the ligand comprising a complex compound containing at least one diaryl phosphino alkyl group and wherein the number of such diaryl phosphino alkyl groups in complex association with said rhodium is at least 2, e.g., (Ph2PCH2CH3)3Rh(CO)H, and (2), a non-complexed ligand substantially all of which is a non-complexed compounds containing at least one diaryl phosphino alkyl group, e.g.. Ar2P(CH2)5PAr2 wherein the molar ratio of non-complexed ligand to rhodium is greater than 75:1 and wherein the ratio of the partial pressures of hydrogen to carbon monoxide is at least 3:1.

  本发明涉及一种连续加氢甲酰化工艺，包括使烯烃化合物与氢和一氧化碳在反应混合物存在下反应，该反应混合物包括(1)含铑催化剂，该催化剂不含活性卤素，且至少有一个配体与所述铑络合，该配体包括至少含有一个二芳基膦烷基的络合物，其中与所述铑络合的二芳基膦烷基的数目至少为2，例如，(Ph2PCH2CH3)3Rh(CO)H，和(2)非络合配体，该非络合配体基本上全部是含有至少一个二芳基膦烷基的非络合物、(Ph2PCH2CH3)3Rh(CO)H，以及(2)，基本上全部为含有至少一个二芳基膦烷基的非络合配体，如Ar2P(CH2)5PAr2，其中非络合配体与铑的摩尔比大于 75:1，氢与一氧化碳的分压比至少为 3:1。
• Symbiotic regenerative agent
  申请人：——

  公开号：US20040076614A1

  公开（公告）日：2004-04-22

  The present invention relates to a regenerative medicament for the natural infection-immunological therapy with induction, regulation and effector mechanisms for the early natural cellular immune defense in humans and animals, comprising a special composition with a microorganism component and a modulator component, to food, food supplements, animal feeds and animal feed supplements containing such composition, and to the use of such composition for the preparation of regenerative agents for the treatment of humans and animals.

  本发明涉及一种用于自然感染-免疫疗法的再生药物，具有诱导、调节和效应机制，可用于人和动物的早期天然细胞免疫防御，该药物包括一种含有微生物成分和调节剂成分的特殊组合物，涉及含有这种组合物的食品、食品补充剂、动物饲料和动物饲料补充剂，以及使用这种组合物制备用于治疗人和动物的再生剂。
• CARBONYLATION PROCESS AND NOVEL TRANSITION METAL CATALYSTS
  申请人：EXXON RESEARCH AND ENGINEERING COMPANY

  公开号：EP0024091A1

  公开（公告）日：1981-02-25
• EP0024091A4
  申请人：——

  公开号：EP0024091A4

  公开（公告）日：1981-07-16
• COMPOUNDS FOR MODULATING DDAH AND ADMA LEVELS, AS WELL AS METHODS OF USING THEREOF TO TREAT DISEASE
  申请人：The Trustees of Indiana University

  公开号：EP3787669A1

  公开（公告）日：2021-03-10